Wednesday 6-25-2014 Ariad Pharmaceuticals (ARIA) $
Post# of 142
Posted On: 06/25/2014 8:18:41 PM
Wednesday 6-25-2014 Ariad Pharmaceuticals (ARIA) $ARIA opened at 6.31 hitting the high price of 6.43 and a day low of 6.26 with a total volume of 5,275,644. ARIA had a previous close of 6.31 and has been seeing an average volume of 7,969,280.
Overall Average: 72% Sell
Recent stock forum discussions about ARIA http://investorshangout.com/search?q=ARIA&...mp;yt0=Go!
Ariad Pharmaceuticals Up 72.2% Since SmarTrend Uptrend Call (ARIA)
Comtex SmarTrend(R) - Wed Jun 25, 9:08AM CDT
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on November 22nd, 2013 at $3.67. In approximately 7 months, Ariad Pharmaceuticals has returned 72.21% as of today's recent price of $6.32. (full story)
Merck KGaA-Mersana Therapeutics Strike a Deal on ADCs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 4:20PM CDT
Merck KGaA (MKGAF) inked a deal with Mersana Therapeutics for the development of next-generation antibody-drug conjugates (ADCs) for the treatment of cancer. (full story)
Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 8:18AM CDT
Ohr Pharmaceutical, Inc. (OHRP) was a big mover last session, as the company saw its shares rise by almost 17% on the day. (full story)
Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 7:35AM CDT
Alcobra stock fell nearly 7% last trading session, reversing its recent uptrend (full story)
Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:46AM CDT
Cardiome Pharma (CRME) was a big mover last session, with shares rising over 7% on the day. (full story)
Genocea Biosciences (GNCA) Jumps: Stock Rises 8.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:39AM CDT
Genocea Biosciences, Inc. (GNCA) was a big mover last session, as its shares rose nearly 9% on the day. (full story)
Heron Therapeutics (HRTX) in Focus: Stock Gains 7.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:25AM CDT
Heron Therapeutics (HRTX) was a big mover last session, with shares rising over 7% on the day. (full story)
Weakness Seen in Cerulean Pharma (CERU): Stock Slumps 20.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 7:57AM CDT
Cerulean Pharma has seen negative earnings estimate revision for the current quarter along with a significant decline in its share price for the last day (full story)
Flamel Technologies (FLML) Jumps: Stock Adds 18.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 7:51AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as its shares rose nearly 19% on the day. (full story)
ARIAD Announces Three Key Appointments to Its Global Management Team
Business Wire - Mon Jun 23, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced the recent appointments of three executives with extensive pharmaceutical industry experience in the areas of global quality, medical affairs, and drug safety and pharmacovigilance. (full story)
FDA Drops the Hammer on Twitter
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun Jun 22, 4:30PM CDT
The FDA just announced new regulations for pharma and biotech companies that wish to promote their drugs via Twitter (Nasdaq: TWTR). Companies cannot brag about a drugs benefits without also tweeting about the associated risks of taking it. There... (full story)
Tetraphase Progresses with Eravacycline Late-Stage Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 4:20PM CDT
Tetraphase Pharmaceuticals (TTPH) announced the completion of patient enrolment for the phase III IGNITE 2 study on eravacycline. (full story)
Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 8:18AM CDT
Aerie Pharmaceuticals, Inc. (AERI) was a big mover last session, as the company saw its shares rise by almost 7% on the day. (full story)
BioLineRx to Commence BL-8040 Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:10PM CDT
BioLineRx Ltd. (BLRX) announced that the Israeli Ministry of Health informed the company that it can start a phase I study on its oncology candidate, BL-8040. (full story)
Endocyte (ECYT) in Focus: Stock Tanks 14% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 7:56AM CDT
Endocyte, Inc. (ECYT) saw a big move last session,reversing the most recent trend for ECYT as the stock is now up around 7.6% since June 3, 2014 (full story)
Receptos (RCPT) in Focus: Stock Up 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 7:51AM CDT
Receptos, Inc. (RCPT) was a big mover last session, as its shares rose nearly 7% on the day. (full story)
Flexion Therapeutics, Inc. (FLXN) Soars: Stock Adds 15.7% in Session - Tale of the Tape
Abhijit Ghosh - Zacks Investment Research - Thu Jun 19, 7:30AM CDT
Flexion Therapeutics, Inc. (FLXN) was a big mover last session, as its shares rose nearly 16% on the day. (full story)
Merck KGaA-Ono Pharma Deal Ends - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 5:15PM CDT
Merck KGaA (MKGAF) has decided to terminate its license agreement with Ono Pharma related to the development of Ono Pharma's multiple sclerosis candidate, ceralifimod (ONO-4641). (full story)
Merck Backs Out of Endocyte Vintafolide Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 11:10AM CDT
Endocyte, Inc. (ECYT) announced that it has regained worldwide rights to oncology candidate, vintafolide, as Merck decided to discontinue its investment in the development of vintafolide. (full story)
Portola Pharmaceuticals, Inc. (PTLA) in Focus Stock Up 5.72% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 7:44AM CDT
Portola Pharmaceuticals, Inc. (PTLA) was a big mover last session, as the company saw its shares gain nearly 6% on the day. (full story)
Overall Average: 72% Sell
Recent stock forum discussions about ARIA http://investorshangout.com/search?q=ARIA&...mp;yt0=Go!
Ariad Pharmaceuticals Up 72.2% Since SmarTrend Uptrend Call (ARIA)
Comtex SmarTrend(R) - Wed Jun 25, 9:08AM CDT
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on November 22nd, 2013 at $3.67. In approximately 7 months, Ariad Pharmaceuticals has returned 72.21% as of today's recent price of $6.32. (full story)
Merck KGaA-Mersana Therapeutics Strike a Deal on ADCs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 4:20PM CDT
Merck KGaA (MKGAF) inked a deal with Mersana Therapeutics for the development of next-generation antibody-drug conjugates (ADCs) for the treatment of cancer. (full story)
Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 8:18AM CDT
Ohr Pharmaceutical, Inc. (OHRP) was a big mover last session, as the company saw its shares rise by almost 17% on the day. (full story)
Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 7:35AM CDT
Alcobra stock fell nearly 7% last trading session, reversing its recent uptrend (full story)
Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:46AM CDT
Cardiome Pharma (CRME) was a big mover last session, with shares rising over 7% on the day. (full story)
Genocea Biosciences (GNCA) Jumps: Stock Rises 8.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:39AM CDT
Genocea Biosciences, Inc. (GNCA) was a big mover last session, as its shares rose nearly 9% on the day. (full story)
Heron Therapeutics (HRTX) in Focus: Stock Gains 7.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:25AM CDT
Heron Therapeutics (HRTX) was a big mover last session, with shares rising over 7% on the day. (full story)
Weakness Seen in Cerulean Pharma (CERU): Stock Slumps 20.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 7:57AM CDT
Cerulean Pharma has seen negative earnings estimate revision for the current quarter along with a significant decline in its share price for the last day (full story)
Flamel Technologies (FLML) Jumps: Stock Adds 18.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 7:51AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as its shares rose nearly 19% on the day. (full story)
ARIAD Announces Three Key Appointments to Its Global Management Team
Business Wire - Mon Jun 23, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced the recent appointments of three executives with extensive pharmaceutical industry experience in the areas of global quality, medical affairs, and drug safety and pharmacovigilance. (full story)
FDA Drops the Hammer on Twitter
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun Jun 22, 4:30PM CDT
The FDA just announced new regulations for pharma and biotech companies that wish to promote their drugs via Twitter (Nasdaq: TWTR). Companies cannot brag about a drugs benefits without also tweeting about the associated risks of taking it. There... (full story)
Tetraphase Progresses with Eravacycline Late-Stage Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 4:20PM CDT
Tetraphase Pharmaceuticals (TTPH) announced the completion of patient enrolment for the phase III IGNITE 2 study on eravacycline. (full story)
Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 8:18AM CDT
Aerie Pharmaceuticals, Inc. (AERI) was a big mover last session, as the company saw its shares rise by almost 7% on the day. (full story)
BioLineRx to Commence BL-8040 Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:10PM CDT
BioLineRx Ltd. (BLRX) announced that the Israeli Ministry of Health informed the company that it can start a phase I study on its oncology candidate, BL-8040. (full story)
Endocyte (ECYT) in Focus: Stock Tanks 14% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 7:56AM CDT
Endocyte, Inc. (ECYT) saw a big move last session,reversing the most recent trend for ECYT as the stock is now up around 7.6% since June 3, 2014 (full story)
Receptos (RCPT) in Focus: Stock Up 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 7:51AM CDT
Receptos, Inc. (RCPT) was a big mover last session, as its shares rose nearly 7% on the day. (full story)
Flexion Therapeutics, Inc. (FLXN) Soars: Stock Adds 15.7% in Session - Tale of the Tape
Abhijit Ghosh - Zacks Investment Research - Thu Jun 19, 7:30AM CDT
Flexion Therapeutics, Inc. (FLXN) was a big mover last session, as its shares rose nearly 16% on the day. (full story)
Merck KGaA-Ono Pharma Deal Ends - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 5:15PM CDT
Merck KGaA (MKGAF) has decided to terminate its license agreement with Ono Pharma related to the development of Ono Pharma's multiple sclerosis candidate, ceralifimod (ONO-4641). (full story)
Merck Backs Out of Endocyte Vintafolide Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 11:10AM CDT
Endocyte, Inc. (ECYT) announced that it has regained worldwide rights to oncology candidate, vintafolide, as Merck decided to discontinue its investment in the development of vintafolide. (full story)
Portola Pharmaceuticals, Inc. (PTLA) in Focus Stock Up 5.72% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 7:44AM CDT
Portola Pharmaceuticals, Inc. (PTLA) was a big mover last session, as the company saw its shares gain nearly 6% on the day. (full story)
(0)
(0)